Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic ear drops added to oral analgesics in children with acute otitis media
2021-003019-24Phase 3Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine in acute otitis media (AOM) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Mean parent-reported ear pain score over first three days. Started Jul 2021; status: terminated.
02
Drugs
lidocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2021-003019-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003019-24.